Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential

Published:2020-01-19 Issue:11 Volume:17 Page:1550-1559
ISSN:1547-6286
Container-title:RNA Biology
language:en
Short-container-title:RNA Biology

Author:

Lee Joo-Hyung¹,Xiong Feng¹^ORCID,Li Wenbo¹²^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA

2. Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center and UTHealth, Houston, TX, USA

Funder

Cancer Prevention and Research Institute of Texas

National Cancer Institute

National Institute of General Medical Sciences

The University of Texas

Welch Foundation

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15476286.2020.1712895

Reference123 articles.

1. Landscape of transcription in human cells

2. Pervasive Transcription of the Human Genome Produces Thousands of Previously Unidentified Long Intergenic Noncoding RNAs

3. Noncoding Transcription at Enhancers: General Principles and Functional Models

4. An atlas of active enhancers across human cell types and tissues

5. Enhancers as non-coding RNA transcription units: recent insights and future perspectives

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. hnRNPA0 promotes MYB expression by interacting with enhancer lncRNA MY34UE-AS in human leukemia cells;Biochemical and Biophysical Research Communications;2024-09

2. Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer;Translational Oncology;2024-07

3. Downregulation of enhancer RNA AC003092.1 is associated with poor prognosis in kidney renal clear cell carcinoma;Scientific Reports;2024-06-12

4. CCAT1 lncRNA is chromatin-retained and post-transcriptionally spliced;Histochemistry and Cell Biology;2024-05-19

5. Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer;Frontiers in Pharmacology;2024-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3